How Value Analysis Committees’ Lines of Questioning Can Directly Affect Value Equation Outputs

By AHRMM

John Kelty from W.L. Gore & Associates discusses how value analysis committees can determine a medical devices value when evaluating new products. 

Related Resources

Podcasts
Join Ken Cyr, Director of Supply Chain Consulting at Intalere, as he discusses how supply chain should be a strategic resource as part of an integr
Webcast
Roy Henry, strategic analyst from University of Miami, explores how clinical integration can evolve your supply chain while discussing the value of
Webcast
In today’s value based health care market, reimbursement is tied to patient outcomes.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.
Webcast
Annie Weisbrod, principal scientist at Procter and Gamble, discusses the science behind sustainable hygiene products in this free AHRMM webcast.
Webcast
AHRMM presents a four-part series on successful collaboration with suppliers.